Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Draft Guidance for Products Incorporating Genome Editing
-
Group Sign-on Letter Concerning the VALID Act of 2022 Discussion Draft
-
ACMG Response to Opposing Inclusion of the VALID Act in the FDASLA Act
-
ACMG Letter of Support for the Right Drug Dose Now Act
-
Group Sign-On Letter Urging CLIAC to Discuss CLIA Modernization
-
Group Sign-On Letter Supporting the VITAL Act
-
ACMG Letter to Congress about Medicaid Coverage of Genetic and Genomic Testing
-
Group Sign-on Letter to Aetna Urging Coverage of CPT Code 99072 in Response to the Public Health Emergency
-
Group Sign-on Letter to Humana Urging Coverage of CPT Code 99072 in Response to the Public Health Emergency
-
Group Sign-on Letter to UHC Urging Coverage of CPT Code 99072 in Response to the Public Health Emergency